×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • VIVO CAPITAL, LLC (Data extracted from 13F, 13D, 13G and Form 4)

VIVO CAPITAL, LLC

AUM: $5.81 B
13-F Portfolio Value: $977.11 M
Last 13-F Filed: Q2 2025
Concentration in top 10: 75%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
SVASinovac Biotech Ltd.3.91%5,903,000$38,192,4105,903,000New$6.4713F
CTMXCytomx Therapeutics Inc1.34%5,769,230$13,096,1525,769,230New$2.2713F
DBVTDBV Technologies SA0.99%1,054,506$9,659,1701,054,506New$9.1613F
PRAXPraxis Precision Medicines0.72%167,600$7,047,580167,600New$42.0513F
UNCYUnicycive Therapeutics0.56%1,137,015$5,423,5621,137,015New$4.7713F
TNGXTango Therapeutics Inc0.31%600,000$3,072,000600,000New$5.1213F
BOLTBolt Therapeutics Inc0.1%176,064$985,958176,064New$5.613F